Skip to content

The Dermatologic Company

Active Private limited companyfounded 2022active for 4 yearsVronerodelaan 119, 1180 UccleKBO/BCE: BE 0792.179.796

Lifetime

3 annual accounts with figures on one time axis
peak of €276,235 in 2025
€276,235▲ 183%
peak of €213,602 in 2025
€213,602▲ 207%
peak of €481,522 in 2025
€481,522▲ 79.7%
€84,069▲ 270%
Board1 name since 2022
1 director
Documentsfilings and deeds
03-02-2026178 days before the deadline
2025micro format
Gross margin from €97,520 to €276,235Result from €69,555 to €213,602Equity from €267,919 to €481,522Debts from €22,740 to €84,069Cash from €107,139 to €244,159

Key points

from the 2025 annual accounts

Equity

€481,522 ▲ 79.7%

The Dermatologic Company has made a profit in every financial year since 2023.

Result

€213,602 ▲ 207%
€69,6002024€214,0002025

The result rose in 2025 from €69,555 to €213,602.

Turnover

≈ €420,000 estimated

The micro format states no turnover.

Debts

€84,069 ▲ 270%
Taxes and wages
+59,367
Suppliers
+84
The rest
+1,879

Debts rose by €61,329 in 2025.

Liquidity

6.82 was 13.01 in 2024

Short-term debts rose from €19,216 to €78,666.

Position in the sector

€213,602

Higher net result than 89% of companies in human health. Sector median €59,553 · 21,334 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 3,137 companies had the same profile as The Dermatologic Company has now. Each dot stands for 8 companies, two years later.

97.0%
were still trading
2.1%
stopped another way
0.8%
went bankrupt
  • Small
  • 2 to 5 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,962 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 3,137 companies, not a prediction for The Dermatologic Company. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 07-10-2022
  • 100 sharesdeed of 11-10-2022
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0792179796
Registered office moved within Uccle The registered office moved from Waterloosesteenweg 1342 bus 3, 1180 Ukkel to Vronerodelaan 119, 1180 Ukkel · acts as permanent representative · General meeting of 19-06-2023 · Gazette deed
Incorporation Founding capital of €100, 100 shares · Founded by (comparant) · appointed as director · published on 11-10-2022 · Gazette deed
First establishment Vronerodelaan 119, Uccle
All 11 events

Comparable companies

same main activity, similar in size and age
Company
The Dermatologic Company Uccle €565,591 €276,235 85.1% -
Docteur Alexandre Boulanger Anesthésiologie Uccle €511,432 €258,879 82.0% -
DERMATO BRUSSELS Anderlecht €551,429 €249,262 91.4% -
NERANESTH Etterbeek €606,965 €245,070 88.8% -
Maria del Carmen Cruz-Conde Rodriguez-Guerra Radiologie Maldegem €583,472 €287,599 88.5% -
Brecht Pauwels Antwerp €589,616 €300,159 87.8% -
VEDERE Ghent €608,802 €262,083 0.8% -

These companies have the same main activity as The Dermatologic Company: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €511,000 and €609,000, founded between 2022 and 2023.

Official details

Source: KBO
Status
Active since 07-10-2022Normal situation
Activity
Specialist medical practiceNACE 86220
Establishment unit
2.337.266.1711180 Uccle, since 07-10-2022
Financial year end
31 December
Peppol
Reachable since 12-05-2026
Company details

Annual accounts 2025

€565,591▲ 94.6%
Filing
Filed on 03-02-2026, 178 days before the end of the filing period
Financials

Insights on The Dermatologic Company

The Dermatologic Company files the micro format. That format states no turnover. The gross margin rose from €269,107 in 2023 to €276,235 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about The Dermatologic Company

What is the company number of The Dermatologic Company?
The company number of The Dermatologic Company is 0792.179.796. The VAT number is the same number with BE in front: BE 0792.179.796.
Where is The Dermatologic Company based?
The registered office is at Vronerodelaan 119, 1180 Uccle.Company details
What does The Dermatologic Company do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of The Dermatologic Company?
The Dermatologic Company is a private limited company (BV).
When was The Dermatologic Company founded?
The Dermatologic Company was founded on 07-10-2022.
Is The Dermatologic Company still active?
Yes, The Dermatologic Company is an active enterprise in the KBO register.
What is the turnover of The Dermatologic Company?
The turnover in financial year 2025 is ≈ €420,000. This figure is estimated from the gross margin of €276,235 and 31 comparable companies (NACE 86220). It probably lies between €370,000 and €580,000.Financials
Is The Dermatologic Company profitable?
In financial year 2025, The Dermatologic Company made a profit of €213,602.
Where can I find the annual accounts of The Dermatologic Company?
The Dermatologic Company filed 3 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of The Dermatologic Company due?
The Dermatologic Company must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.